Global Respiratory Syncytial Virus (RSV) diagnostics market is expected to reach USD 1.2 billion by 2022, according to a new study by Grand View Research Inc. Increasing neonatal population suffering from respiratory conditions including RSV infections and supportive initiatives for diagnosis of newborns by the healthcare providers are expected to be vital impact rendering drivers for RSV diagnostics market.
According to the statistics provided by the WHO, hospitalization of over 150,000 children (below the age of five) and about 14,000 deaths in geriatric patients occurred in the U.S. in 2014 due to RSV infections. This is anticipated to trigger demand for testing of these conditions over the forecast period.
Browse Detail Report With TOC @ http://www.hexareports.com/report/respiratory-syncytial-virus-diagnostics-market/details
Furthermore, the global birth rate as of 2014 is 18.7 births per 1,000 individuals, which is predicted to increase the infant population substantially over the next seven years. According to the statistics, it is estimated that about 134.2 million births took place in 2014, which are prone to RSV infections and require diagnosis, thus forming a large market base.
In 2010, Save Babies Through Screening Foundation (SBTS) entered in a partnership with World Solutions Against Infectious Disease (WSAID) as an attempt to promote higher screening of newborns for infectious diseases, metabolic disorders, and hearing disabilities.
Further key findings from the study suggest:
Chromatographic immunoassay technology based products are expected to witness the fastest growth at a CAGR above 10.0% over the next seven years owing to their higher specificity than molecular diagnostic products. The commercially available test kits include Binax Now RSV, QuickLab RSV Test, Remel Xpect, and RSV Respi-Strip.
Hospitals are predicted to dominate the RSV diagnostics market followed by home care. Together, they are expected to contribute over 50.0% of the market share in 2022. Increasing demand for home care diagnostic devices by patients is anticipated to drive growth of the segment over the next seven years.
North America is anticipated to dominate the market and contribute a revenue share of over 40.0% by 2022. Rising awareness among the population base and favorable initiatives by the government agencies such as the WHO, PAHO, and WSAID to initiate and implement newborn screening are expected to drive growth.
Key players of the market include Alere Inc., EMD Millipore, BD and Company, Ortho Clinical Diagnostics, Roche Diagnostics, Abbott Laboratories, and Thermo Fisher Scientific Inc. CLIA waiver and launch of RSV assays by companies like Roche Diagnostics, Becton Dickinson and Company, and Alere Inc. are expected to boost market growth over the forecast peri
Global Bone Cement Industry 2016 Market Research Report:
China Cellulose Powder Industry 2016 Market Research Report:
Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Respiratory Syncytial Virus Diagnostics Market- Industry Snapshot and Key Buying Criteria, 2014
Chapter 3. Global Respiratory Syncytial Virus Diagnostics (RSV) Market Industry Outlook
3.1. Respiratory Syncytial Virus Diagnostics Market: Segmentation
3.2. Respiratory Syncytial Virus Diagnostics Market: Size And Growth Prospects
3.3. Respiratory Syncytial Virus Diagnostics Market: Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Key Opportunities Prioritized
3.5. Industry Analysis – Porter’s
3.6. Respiratory Syncytial Virus Diagnostics Company Market Share, 2014
3.7. Respiratory Syncytial Virus Diagnostics Market: PESTEL Analysis, 2014
3.8. Respiratory Syncytial Virus Diagnostics Technology Overview
Chapter 4. Global Respiratory Syncytial Virus Diagnostics (RSV) Market Product Outlook
4.1. Respiratory Syncytial Virus Diagnostics Market Share, By Product, 2014 & 2022
4.2. Direct Fluorescence Antibody (DFA) Method
4.2.1. Direct Fluorescence Antibody (DFA) Method Market Estimates And Forecasts, 2012 – 2022 (USD Million)
4.3. Rapid Antigen Diagnostic Test(RADTs)
4.3.1. Rapid Antigen Diagnostic Test (RADTs) Market Estimates And Forecasts, 2012 – 2022 (USD Million)
4.4. Molecular Diagnostics
4.4.1. Molecular Diagnostics Market Estimates And Forecasts, 2012 – 2022 (USD Million)
4.5. Chromatographic Immunoassay
4.5.1. Chromatographic Immunoassay Market Estimates And Forecasts, 2012 – 2022 (USD Million)
4.6. Diagnostic Imaging
4.6.1. Diagnostic Imaging Market Estimates And Forecasts, 2012 – 2022 (USD Million)
4.7. Gel Microdroplets
4.7.1. Gel Microdroplets Market Estimates And Forecasts, 2012 – 2022 (USD Million)
4.8. Flow Cytometry
4.8.1. Flow Cytometry Market Estimates And Forecasts, 2012 – 2022 (USD Million)
4.9.1. Other Market Estimates And Forecasts, 2012 – 2022 (USD Million)
Request A Sample copy of This Report @ http://www.hexareports.com/sample/112534
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Company Name: Hexa Reports
Contact Person: Ryan Shaw
Address:Felton Office Plaza, 6265 Highway 9
Country: United States